Chong Bai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Chong Bai has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
Qiang Li
Department of Respiratory, Oriental Hospital, Tongji University, Shanghai, China
13 shared publicationsHaidong Huang
Department of Respiratory and Critical Care Medicine, Changhai Hospital, Navy Military Medical University, Shanghai, 200433, China
8 shared publications- Paul Zarogoulidis
Pulmonary Department, General Clinic Euromedica, Thessaloniki, Greece
7 shared publications - Xiao-Peng Yao
Department of Respiratory Medicine, Changhai Hospital, Second Military Medical University, Shanghai, China
7 shared publications Yi Huang
6 shared publicationsKosmas Tsakiridis
Thoracic Surgery Department, ''Interbalkan'' European Medical Center, Thessaloniki, Greece
5 shared publications
Latest Publications
- Open Access
Positron Emission-Computed Tomography, Cryobiopsy versus Bronchoalveolar Lavage and Computed Tomography Findings for Interstitial Lung Disease: A Long-Term Follow-Up
Background and Objectives: Interstitial lung diseases have always been an issue for pulmonary and rheumatology physicians. Computed tomography scans with a high-resolution protocol and bronchoalveolar lavage have been used along with biochemical blood tests to reach a diagnosis. Materials and Methods: We included 80 patients in total. First, all patients had their diagnosis with computed tomography of the thorax, serological/ immunological blood tests and bronchoalveolar lavage. However; after 3 months, all were divided into 2 groups: those who had bronchoalveolar lavage again and those who had cryobiopsy instead of bronchoalveolar lavage (40/40). Positron emission-computed tomography was also performed upon the first and second diagnosis. The patients’ follow-up was 4 years from diagnosis. Results: Patients suffered most from chronic obstructive pulmonary disease (56, 70%), while lung cancer was rarely encountered in the sample (7, 9.75%). Age distribution ranged between 53 and 68 years with a mean value of 60 years. The computed tomography findings revealed 25 patients with typical diagnosis (35.2%), 17 with interstitial pulmonary fibrosis (23.9%) and 11 with probable diagnosis (11%). The cryobiopsy technique led to a new diagnosis in 28 patients (35% of the total sample). Patients who had a new diagnosis with cryobiopsy had a mean survival time of 710 days (Conclusions: Cryobiopsy is a safe tool for patients with interstitial lung disease and can assist in the diagnosis of interstitial lung diseases. The survival of patients was increased in the cryobiopsy group versus only bronchoalveolar lavage for disease diagnosis.
Open AccessPositron Emission-Computed Tomography, Cryobiopsy versus Bronchoalveolar Lavage and Computed Tomography Findings for Interstitial Lung Disease: A Long-Term Follow-Up
Background and Objectives: Interstitial lung diseases have always been an issue for pulmonary and rheumatology physicians. Computed tomography scans with a high-resolution protocol and bronchoalveolar lavage have been used along with biochemical blood tests to reach a diagnosis. Materials and Methods: We included 80 patients in total. First, all patients had their diagnosis with computed tomography of the thorax, serological/ immunological blood tests and bronchoalveolar lavage. However; after 3 months, all were divided into 2 groups: those who had bronchoalveolar lavage again and those who had cryobiopsy instead of bronchoalveolar lavage (40/40). Positron emission-computed tomography was also performed upon the first and second diagnosis. The patients’ follow-up was 4 years from diagnosis. Results: Patients suffered most from chronic obstructive pulmonary disease (56, 70%), while lung cancer was rarely encountered in the sample (7, 9.75%). Age distribution ranged between 53 and 68 years with a mean value of 60 years. The computed tomography findings revealed 25 patients with typical diagnosis (35.2%), 17 with interstitial pulmonary fibrosis (23.9%) and 11 with probable diagnosis (11%). The cryobiopsy technique led to a new diagnosis in 28 patients (35% of the total sample). Patients who had a new diagnosis with cryobiopsy had a mean survival time of 710 days (Conclusions: Cryobiopsy is a safe tool for patients with interstitial lung disease and can assist in the diagnosis of interstitial lung diseases. The survival of patients was increased in the cryobiopsy group versus only bronchoalveolar lavage for disease diagnosis.
- Open Access
- 20 June 2022
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 39, 101687
Corrigendum to “Tentative study on radial endobronchial ultrasonography evaluating airway wall thickness before and after bronchial thermoplasty” [Respir. Med. Case Rep. 36 (2022) 101571]
- 20 June 2022
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 39, 101687
Open AccessCorrigendum to “Tentative study on radial endobronchial ultrasonography evaluating airway wall thickness before and after bronchial thermoplasty” [Respir. Med. Case Rep. 36 (2022) 101571]
- Open Access
- 1 May 2022
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 14 (5) , 1674-1683
A narrative review of progress in airway stents
Review Article A narrative review of progress in airway stents Sen Tian, Haidong Huang, Zhenli Hu, Yuchao Dong, Chong Bai
- 1 May 2022
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 14 (5) , 1674-1683
Open AccessA narrative review of progress in airway stents
Review Article A narrative review of progress in airway stents Sen Tian, Haidong Huang, Zhenli Hu, Yuchao Dong, Chong Bai
- Open Access
- 17 March 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (6) , 3569
Radial-EBUS: CryoBiopsy Versus Conventional Biopsy: Time-Sample and C-Arm
Introduction: Diagnosis of lung nodules is still under investigation. We use computed tomography scans and positron emission tomography in order to identify their origin. Patients and Methods: In our retrospective study, we included 248 patients with a single lung nodule or multiple lung nodules of size ≥1 cm. We used a radial-endobronchial ultrasound and a C-Arm. We used a 1.1 mm cryoprobe versus a 22G needle vs. forceps/brush. We compared the sample size of each biopsy method with the number of cell-block slices. Results: Central lesions indifferent to the method provided the same mean number of cell-block slices (0.04933–0.02410). Cryobiopsies provide less sample size for peripheral lesions due to the higher incidence of pneumothorax (0.04700–0.02296). Conclusion: The larger the lesion ≥2 cm, and central, more cell-blocks are produced indifferent to the biopsy method (0.13386–0.02939). The time of the procedure was observed to be less when the C-Arm was used as an additional navigation tool (0.14854–0.00089).
- 17 March 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (6) , 3569
Open AccessRadial-EBUS: CryoBiopsy Versus Conventional Biopsy: Time-Sample and C-Arm
Introduction: Diagnosis of lung nodules is still under investigation. We use computed tomography scans and positron emission tomography in order to identify their origin. Patients and Methods: In our retrospective study, we included 248 patients with a single lung nodule or multiple lung nodules of size ≥1 cm. We used a radial-endobronchial ultrasound and a C-Arm. We used a 1.1 mm cryoprobe versus a 22G needle vs. forceps/brush. We compared the sample size of each biopsy method with the number of cell-block slices. Results: Central lesions indifferent to the method provided the same mean number of cell-block slices (0.04933–0.02410). Cryobiopsies provide less sample size for peripheral lesions due to the higher incidence of pneumothorax (0.04700–0.02296). Conclusion: The larger the lesion ≥2 cm, and central, more cell-blocks are produced indifferent to the biopsy method (0.13386–0.02939). The time of the procedure was observed to be less when the C-Arm was used as an additional navigation tool (0.14854–0.00089).
- Open Access
- 1 January 2022
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 13 (4) , 1307-1312
Radial Endobronchial Ultrasound for Lung Cancer Diagnosis: Tips and Tricks
Introduction: Endoscopic techniques have been upgraded in the recent 10 years. We can use the radial endobronchial ultrasound to reach distal nodules in the periphery of the lungs, but also we can use it in order to make biopsies in lesions without endobronchial findings.
- 1 January 2022
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 13 (4) , 1307-1312
Open AccessRadial Endobronchial Ultrasound for Lung Cancer Diagnosis: Tips and Tricks
Introduction: Endoscopic techniques have been upgraded in the recent 10 years. We can use the radial endobronchial ultrasound to reach distal nodules in the periphery of the lungs, but also we can use it in order to make biopsies in lesions without endobronchial findings.
- Open Access
- 1 January 2021
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 12 (19) , 5874-5878
Priority of PET-CT vs CT Thorax for EBUS-TBNA 22G vs 19G: Mesothorax Lymphadenopathy
Introduction: Lung lesions and undiagnosed mesothorax lymphadenopathy is an issue that several doctors face in the everyday clinical practice. PET-CT and CT of the thorax are usually the first examinations to identify characteristics of the lesions before biopsy.
- 1 January 2021
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 12 (19) , 5874-5878
Open AccessPriority of PET-CT vs CT Thorax for EBUS-TBNA 22G vs 19G: Mesothorax Lymphadenopathy
Introduction: Lung lesions and undiagnosed mesothorax lymphadenopathy is an issue that several doctors face in the everyday clinical practice. PET-CT and CT of the thorax are usually the first examinations to identify characteristics of the lesions before biopsy.
- Open Access
- 1 January 2021
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 12 (9) , 2560-2569
Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G
Introduction: Immunotherapy is being used for the past five years either as first line or second line treatment with great results. Chemotherapy and radiotherapy have been also used as combination to immunotherapy to further enhance this type of treatment. Intratumoral treatment has been previously proposed as a treatment option for certain non-small cell lung cancer patients.
- 1 January 2021
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 12 (9) , 2560-2569
Open AccessIntratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G
Introduction: Immunotherapy is being used for the past five years either as first line or second line treatment with great results. Chemotherapy and radiotherapy have been also used as combination to immunotherapy to further enhance this type of treatment. Intratumoral treatment has been previously proposed as a treatment option for certain non-small cell lung cancer patients.
- Open Access
- 1 January 2020
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 11 (19) , 5547-5555
The development of bronchoscopy in China: a national cross-sectional study
Objective: To investigate the development of bronchoscopy in China and compare it with its application in the early 21st century.
- 1 January 2020
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 11 (19) , 5547-5555
Open AccessThe development of bronchoscopy in China: a national cross-sectional study
Objective: To investigate the development of bronchoscopy in China and compare it with its application in the early 21st century.
- 1 April 2019
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 11 (4) , 1651-1661
Occupational adverse effects and protective factors in bronchoscopy
The application of bronchoscopy has resolved a series of diagnostic and treatment challenges in pulmonary diseases. However, the occupational adverse effects experienced by healthcare workers in interventional pulmonology should receive increasing attention. Various aspects of adverse effects in bronchoscopy are often neglected, and healthcare workers frequently ignore guidelines for personal protection against factors such as radiation, smoke, pathogenic microbiological aerosols, cryogenic gas, etc. Thus, there is an urgent need to conduct additional research to establish standards for occupational adverse effects and protective measures related to bronchoscopy.
- 1 April 2019
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 11 (4) , 1651-1661
Occupational adverse effects and protective factors in bronchoscopy
The application of bronchoscopy has resolved a series of diagnostic and treatment challenges in pulmonary diseases. However, the occupational adverse effects experienced by healthcare workers in interventional pulmonology should receive increasing attention. Various aspects of adverse effects in bronchoscopy are often neglected, and healthcare workers frequently ignore guidelines for personal protection against factors such as radiation, smoke, pathogenic microbiological aerosols, cryogenic gas, etc. Thus, there is an urgent need to conduct additional research to establish standards for occupational adverse effects and protective measures related to bronchoscopy.
- Open Access
- 1 July 2018
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 10 (S18) , S2217-S2218
Rigid bronchoscopy in mainland China: present state and perspectives
Rigid bronchoscopy in mainland China: present state and perspectives
- 1 July 2018
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 10 (S18) , S2217-S2218
Open AccessRigid bronchoscopy in mainland China: present state and perspectives
Rigid bronchoscopy in mainland China: present state and perspectives